QIAGEN N.V. (NYSE: QGEN) announced it has entered into a definitive agreement to acquire Parse Biosciences, a provider of single-cell ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE